text: Yo, check it out, listen close, I got something to say,
  Introducing CB1a, a custom peptide in the game,
  Anti-lung cancer, it's here to make a change,
  With an IC₅₀ of 25.0 ± 1.6 μM, it's putting cells in their place.
  
  NCI-H460, lung cancer cells, step aside,
  CB1a's coming through, gonna take you for a ride,
  In the MCTS model, it's a sight to behold,
  Stopping tumor-like growths, that's how it rolls.
  
  Atomic force microscopy, examining the scene,
  Cell surface damage, where CB1a gets mean,
  Cell death caused by toxicity, that's the real deal,
  CB1a's doing work, proving it's for real.
  
  At a dosage of 25 μM, things start to shift,
  Young's modulus (E) showing cells losing their grip,
  Elasticity and stiffness, decreasing with time,
  In just 7.0 minutes, a 50% reduction, it's a rhyme.
  
  IT₅₀, that's the interaction time we see,
  Under AFM assay, revealing toxicity,
  Separate from the IC₅₀, this method's unique,
  Verifying drug efficacy, it's what we seek.
  
  Researchers in the house, pay attention, take note,
  These results are gold, they'll help you stay afloat,
  New drug development, this info's on the rise,
  CB1a's the future, it's a big surprise.